---
title: "MXCT.US (MXCT.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/MXCT.US/news.md"
symbol: "MXCT.US"
name: "MXCT.US"
parent: "https://longbridge.com/en/quote/MXCT.US.md"
datetime: "2026-05-19T21:48:42.644Z"
locales:
  - [en](https://longbridge.com/en/quote/MXCT.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MXCT.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MXCT.US/news.md)
---

# MXCT.US (MXCT.US) — Related News

### [River Global Investors Discloses Investment in MaxCyte with 6.1% Stake](https://longbridge.com/en/news/286427947.md)
*2026-05-14T13:46:01.000Z*
> River Global Investors LLP has disclosed a 6.095% stake in MaxCyte, Inc., following open-market purchases on May 13, 202

### [MaxCyte | 10-Q: FY2026 Q1 Revenue Beats Estimate at USD 9.651 M](https://longbridge.com/en/news/286314397.md)
*2026-05-13T20:37:49.000Z*
### [12 Health Care Stocks Moving In Wednesday's Intraday Session](https://longbridge.com/en/news/286296422.md)
*2026-05-13T17:06:16.000Z*
> In Wednesday's intraday session, Quantum Cyber (NASDAQ:QUCY) saw a significant gain of 163.0%, reaching $0.85, while Whi

### [MaxCyte (MXCT) Gets a Buy from Stifel Nicolaus](https://longbridge.com/en/news/286285778.md)
*2026-05-13T15:16:40.000Z*
> MaxCyte (MXCT) has received a Buy rating from Stifel Nicolaus, with a price target of $4.00, as reported by Daniel Arias

### [Cisco, Alibaba And 3 Stocks To Watch Heading Into Wednesday](https://longbridge.com/en/news/286223946.md)
*2026-05-13T08:14:25.000Z*
> U.S. stock futures are mixed as investors watch key earnings reports. Cisco Systems is expected to report earnings of $1

### [](https://longbridge.com/en/news/286252593.md)
*2026-05-12T20:58:43.000Z*
> MaxCyte shares are trading higher after the company reported better-than-expected Q1 financial results.

### [Craig-Hallum Remains a Buy on MaxCyte (MXCT)](https://longbridge.com/en/news/286155462.md)
*2026-05-12T20:39:52.000Z*
> Craig-Hallum analyst Matt Hewitt has maintained a Buy rating on MaxCyte (MXCT), with shares closing at $0.82. The analys

### [MaxCyte | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 9.651 M](https://longbridge.com/en/news/286151950.md)
*2026-05-12T20:22:27.000Z*
### [<![CDATA[Pharmaceutical Executive Daily: FDA Approves Caplyta for Adults with Schizophrenia]]>](https://longbridge.com/en/news/284258481.md)
*2026-04-27T18:24:38.000Z*
> Eli Lilly has agreed to acquire Ajax Therapeutics for up to $2.3 billion, enhancing its oncology pipeline with a JAK2 in